Two Sigma Investments, LP Aytu Biopharma, Inc Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
SELL
$0.15 - $4.0 $1,722 - $45,944
-11,486 Reduced 43.5%
14,917 $2,000
Q3 2022

Nov 14, 2022
SELL
$0.19 - $3.8 $2,748 - $54,978
-14,468 Reduced 35.4%
26,403 $5,000
Q2 2022

Aug 15, 2022
BUY
$0.46 - $1.08 $18,800 - $44,140
40,871 New
40,871 $28,000

Others Institutions Holding AYTU

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AYTU BIOPHARMA, INC

AYTU Quotes by TradingView
  • Ticker AYTU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 62,432,700
  • Market Cap $101M
  • Description
  • Aytu Biopharma, Inc., a specialty pharmaceutical company, focuses on developing and commercializing novel therapeutics and consumer healthcare products the United States and internationally. The company offers Adzenys XR-ODT for the treatment of attention deficit hyperactivity disorder (ADHD) in patients from 6 years and older; Cotempla XR-ODT f...
More about AYTU
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email